ABT vs CTRN · P/E 25, rev $44.33B vs rev $753.1M
Abbott Laboratories (ABT) versus Citi Trends Inc (CTRN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Citi Trends Inc (CTRN) is a apparel retail company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CTRN revenue for 2025-02-01 was $753.1M. Net income was -$43.2M. Revenue was up 0.7% from 2024-02-03 to 2025-02-01. CTRN currently screens at market cap $258.4M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CTRN currently screens at market cap $258.4M.
Not investment advice. Open the ABT and CTRN stock pages for the full models.
Not investment advice.